Zainabadi et al. [130] reported that SIRT1 activation enhanced bone mass and acted as a therapeutic target for osteoporosis, emphasizing the potential of SIRT1 in maintaining BMD and preventing bone loss. This evidence concerns the gene SIRT1 and osteoporosis.